Phenotyping an adult zebrafish lamp2 cardiomyopathy model identifies mTOR inhibition as a candidate therapy
Adult zebrafish is an emerging vertebrate model for studying genetic basis of cardiomyopathies; but whether the simple fish heart can model essential features of hypertrophic cardiomyopathy (HCM) remained unknown. Here, we report a comprehensive phenotyping of a lamp2 knockout (KO) mutant. LAMP2 enc...
Gespeichert in:
Veröffentlicht in: | Journal of molecular and cellular cardiology 2019-08, Vol.133, p.199-208 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 208 |
---|---|
container_issue | |
container_start_page | 199 |
container_title | Journal of molecular and cellular cardiology |
container_volume | 133 |
creator | Dvornikov, Alexey V. Wang, Mingmin Yang, Jingchun Zhu, Ping Le, Tai Lin, Xueying Cao, Hung Xu, Xiaolei |
description | Adult zebrafish is an emerging vertebrate model for studying genetic basis of cardiomyopathies; but whether the simple fish heart can model essential features of hypertrophic cardiomyopathy (HCM) remained unknown. Here, we report a comprehensive phenotyping of a lamp2 knockout (KO) mutant. LAMP2 encodes a lysosomal protein and is a causative gene of Danon disease that is characterized by HCM and massive autophagic vacuoles accumulation in the tissues. There is no effective therapy yet to treat this most lethal cardiomyopathy in the young. First, we did find the autophagic vacuoles accumulation in cardiac tissues from lamp2 KO. Next, through employing a set of emerging phenotyping tools, we revealed heart failure phenotypes in the lamp2 KO mutants, including decreased ventricular ejection fraction, reduced physical exercise capacity, blunted β-adrenergic contractile response, and enlarged atrium. We also noted changes of the following indices suggesting cardiac hypertrophic remodeling in lamp2 KO: a rounded heart shape, increased end-systolic ventricular volume and density of ventricular myocardium, elevated actomyosin activation kinetics together with increased maximal isometric tension at the level of cardiac myofibrils. Lastly, we assessed the function of lysosomal-localized mTOR on the lamp2-associated Danon disease. We found that haploinsufficiency of mtor was able to normalize some characteristics of the lamp2 KO, including ejection fraction, β-adrenergic response, and the actomyosin activation kinetics. In summary, we demonstrate the feasibility of modeling the inherited HCM in the adult zebrafish, which can be used to develop potential therapies.
[Display omitted]
•Zebrafish has a single LAMP2 homologue.•Loss-of-function of lamp2 in zebrafish models human Danon disease•Both metabolic abnormality and cardiac dysfunction are recapitulated.•mtor inhibition attenuates cardiac dysfunction while metabolic abnormality persists. |
doi_str_mv | 10.1016/j.yjmcc.2019.06.013 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6705397</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0022282819301348</els_id><sourcerecordid>2245641678</sourcerecordid><originalsourceid>FETCH-LOGICAL-c459t-a06eb26857f1a4755bee36989642516e2555a27e096919a695a6d7e096436a13</originalsourceid><addsrcrecordid>eNp9kU9v1DAQxS0EokvhEyAhH7kk2E7sxAeQUMU_qVIR2rs1sSeNlyQOtrdS-ulJu6WCC6fRaN57M5ofIa85Kznj6t2hXA-TtaVgXJdMlYxXT8iOMy2LVrb1U7JjTIhCtKI9Iy9SOjDGdF1Vz8lZxYVoJW935Of3AeeQ18XP1xRmCu44ZnqLXYTep4GOMC2CWojOh2kNC-RhpVNwOFLvcM6-95jotL_6Qf08-M5nH7aURGEzzc47yEjzgBGW9SV51sOY8NVDPSf7z5_2F1-Ly6sv3y4-Xha2ljoXwBR2QrWy6TnUjZQdYqV0q1UtJFcopJQgGmRaaa5BaQnK3bd1pYBX5-TDKXY5dhM6u10ZYTRL9BPE1QTw5t_J7AdzHW6MapisdLMFvH0IiOHXEVM2k08WxxFmDMdkhKilqrlq2k1anaQ2hpQi9o9rODN3lMzB3FMyd5QMU2ajtLne_H3ho-cPlk3w_iTA7U03HqNJ1uNs0fmINhsX_H8X_AaeK6YW</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2245641678</pqid></control><display><type>article</type><title>Phenotyping an adult zebrafish lamp2 cardiomyopathy model identifies mTOR inhibition as a candidate therapy</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Dvornikov, Alexey V. ; Wang, Mingmin ; Yang, Jingchun ; Zhu, Ping ; Le, Tai ; Lin, Xueying ; Cao, Hung ; Xu, Xiaolei</creator><creatorcontrib>Dvornikov, Alexey V. ; Wang, Mingmin ; Yang, Jingchun ; Zhu, Ping ; Le, Tai ; Lin, Xueying ; Cao, Hung ; Xu, Xiaolei</creatorcontrib><description>Adult zebrafish is an emerging vertebrate model for studying genetic basis of cardiomyopathies; but whether the simple fish heart can model essential features of hypertrophic cardiomyopathy (HCM) remained unknown. Here, we report a comprehensive phenotyping of a lamp2 knockout (KO) mutant. LAMP2 encodes a lysosomal protein and is a causative gene of Danon disease that is characterized by HCM and massive autophagic vacuoles accumulation in the tissues. There is no effective therapy yet to treat this most lethal cardiomyopathy in the young. First, we did find the autophagic vacuoles accumulation in cardiac tissues from lamp2 KO. Next, through employing a set of emerging phenotyping tools, we revealed heart failure phenotypes in the lamp2 KO mutants, including decreased ventricular ejection fraction, reduced physical exercise capacity, blunted β-adrenergic contractile response, and enlarged atrium. We also noted changes of the following indices suggesting cardiac hypertrophic remodeling in lamp2 KO: a rounded heart shape, increased end-systolic ventricular volume and density of ventricular myocardium, elevated actomyosin activation kinetics together with increased maximal isometric tension at the level of cardiac myofibrils. Lastly, we assessed the function of lysosomal-localized mTOR on the lamp2-associated Danon disease. We found that haploinsufficiency of mtor was able to normalize some characteristics of the lamp2 KO, including ejection fraction, β-adrenergic response, and the actomyosin activation kinetics. In summary, we demonstrate the feasibility of modeling the inherited HCM in the adult zebrafish, which can be used to develop potential therapies.
[Display omitted]
•Zebrafish has a single LAMP2 homologue.•Loss-of-function of lamp2 in zebrafish models human Danon disease•Both metabolic abnormality and cardiac dysfunction are recapitulated.•mtor inhibition attenuates cardiac dysfunction while metabolic abnormality persists.</description><identifier>ISSN: 0022-2828</identifier><identifier>EISSN: 1095-8584</identifier><identifier>DOI: 10.1016/j.yjmcc.2019.06.013</identifier><identifier>PMID: 31228518</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Animals ; Cardiac contractility ; Cardiomegaly - genetics ; Cardiomyopathy ; Danon disease ; Disease modeling ; Disease Models, Animal ; Gene Knockout Techniques ; Glycogen Storage Disease Type IIb - genetics ; Glycogen Storage Disease Type IIb - metabolism ; Hypertrophic remodeling ; Lysosomal-Associated Membrane Protein 2 - genetics ; Lysosomal-Associated Membrane Protein 2 - metabolism ; mTOR ; Myocardial Contraction - genetics ; Myocardium - metabolism ; Myofibrils - metabolism ; Phenotype ; Receptors, Adrenergic, beta - metabolism ; Single myofibril ; Stroke Volume ; TOR Serine-Threonine Kinases - antagonists & inhibitors ; TOR Serine-Threonine Kinases - genetics ; TOR Serine-Threonine Kinases - metabolism ; Ventricular Remodeling - genetics ; Zebrafish ; Zebrafish - genetics ; Zebrafish - metabolism</subject><ispartof>Journal of molecular and cellular cardiology, 2019-08, Vol.133, p.199-208</ispartof><rights>2019 Elsevier Ltd</rights><rights>Copyright © 2019 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c459t-a06eb26857f1a4755bee36989642516e2555a27e096919a695a6d7e096436a13</citedby><cites>FETCH-LOGICAL-c459t-a06eb26857f1a4755bee36989642516e2555a27e096919a695a6d7e096436a13</cites><orcidid>0000-0003-4197-7208</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.yjmcc.2019.06.013$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,776,780,881,3536,27903,27904,45974</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31228518$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Dvornikov, Alexey V.</creatorcontrib><creatorcontrib>Wang, Mingmin</creatorcontrib><creatorcontrib>Yang, Jingchun</creatorcontrib><creatorcontrib>Zhu, Ping</creatorcontrib><creatorcontrib>Le, Tai</creatorcontrib><creatorcontrib>Lin, Xueying</creatorcontrib><creatorcontrib>Cao, Hung</creatorcontrib><creatorcontrib>Xu, Xiaolei</creatorcontrib><title>Phenotyping an adult zebrafish lamp2 cardiomyopathy model identifies mTOR inhibition as a candidate therapy</title><title>Journal of molecular and cellular cardiology</title><addtitle>J Mol Cell Cardiol</addtitle><description>Adult zebrafish is an emerging vertebrate model for studying genetic basis of cardiomyopathies; but whether the simple fish heart can model essential features of hypertrophic cardiomyopathy (HCM) remained unknown. Here, we report a comprehensive phenotyping of a lamp2 knockout (KO) mutant. LAMP2 encodes a lysosomal protein and is a causative gene of Danon disease that is characterized by HCM and massive autophagic vacuoles accumulation in the tissues. There is no effective therapy yet to treat this most lethal cardiomyopathy in the young. First, we did find the autophagic vacuoles accumulation in cardiac tissues from lamp2 KO. Next, through employing a set of emerging phenotyping tools, we revealed heart failure phenotypes in the lamp2 KO mutants, including decreased ventricular ejection fraction, reduced physical exercise capacity, blunted β-adrenergic contractile response, and enlarged atrium. We also noted changes of the following indices suggesting cardiac hypertrophic remodeling in lamp2 KO: a rounded heart shape, increased end-systolic ventricular volume and density of ventricular myocardium, elevated actomyosin activation kinetics together with increased maximal isometric tension at the level of cardiac myofibrils. Lastly, we assessed the function of lysosomal-localized mTOR on the lamp2-associated Danon disease. We found that haploinsufficiency of mtor was able to normalize some characteristics of the lamp2 KO, including ejection fraction, β-adrenergic response, and the actomyosin activation kinetics. In summary, we demonstrate the feasibility of modeling the inherited HCM in the adult zebrafish, which can be used to develop potential therapies.
[Display omitted]
•Zebrafish has a single LAMP2 homologue.•Loss-of-function of lamp2 in zebrafish models human Danon disease•Both metabolic abnormality and cardiac dysfunction are recapitulated.•mtor inhibition attenuates cardiac dysfunction while metabolic abnormality persists.</description><subject>Animals</subject><subject>Cardiac contractility</subject><subject>Cardiomegaly - genetics</subject><subject>Cardiomyopathy</subject><subject>Danon disease</subject><subject>Disease modeling</subject><subject>Disease Models, Animal</subject><subject>Gene Knockout Techniques</subject><subject>Glycogen Storage Disease Type IIb - genetics</subject><subject>Glycogen Storage Disease Type IIb - metabolism</subject><subject>Hypertrophic remodeling</subject><subject>Lysosomal-Associated Membrane Protein 2 - genetics</subject><subject>Lysosomal-Associated Membrane Protein 2 - metabolism</subject><subject>mTOR</subject><subject>Myocardial Contraction - genetics</subject><subject>Myocardium - metabolism</subject><subject>Myofibrils - metabolism</subject><subject>Phenotype</subject><subject>Receptors, Adrenergic, beta - metabolism</subject><subject>Single myofibril</subject><subject>Stroke Volume</subject><subject>TOR Serine-Threonine Kinases - antagonists & inhibitors</subject><subject>TOR Serine-Threonine Kinases - genetics</subject><subject>TOR Serine-Threonine Kinases - metabolism</subject><subject>Ventricular Remodeling - genetics</subject><subject>Zebrafish</subject><subject>Zebrafish - genetics</subject><subject>Zebrafish - metabolism</subject><issn>0022-2828</issn><issn>1095-8584</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kU9v1DAQxS0EokvhEyAhH7kk2E7sxAeQUMU_qVIR2rs1sSeNlyQOtrdS-ulJu6WCC6fRaN57M5ofIa85Kznj6t2hXA-TtaVgXJdMlYxXT8iOMy2LVrb1U7JjTIhCtKI9Iy9SOjDGdF1Vz8lZxYVoJW935Of3AeeQ18XP1xRmCu44ZnqLXYTep4GOMC2CWojOh2kNC-RhpVNwOFLvcM6-95jotL_6Qf08-M5nH7aURGEzzc47yEjzgBGW9SV51sOY8NVDPSf7z5_2F1-Ly6sv3y4-Xha2ljoXwBR2QrWy6TnUjZQdYqV0q1UtJFcopJQgGmRaaa5BaQnK3bd1pYBX5-TDKXY5dhM6u10ZYTRL9BPE1QTw5t_J7AdzHW6MapisdLMFvH0IiOHXEVM2k08WxxFmDMdkhKilqrlq2k1anaQ2hpQi9o9rODN3lMzB3FMyd5QMU2ajtLne_H3ho-cPlk3w_iTA7U03HqNJ1uNs0fmINhsX_H8X_AaeK6YW</recordid><startdate>20190801</startdate><enddate>20190801</enddate><creator>Dvornikov, Alexey V.</creator><creator>Wang, Mingmin</creator><creator>Yang, Jingchun</creator><creator>Zhu, Ping</creator><creator>Le, Tai</creator><creator>Lin, Xueying</creator><creator>Cao, Hung</creator><creator>Xu, Xiaolei</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-4197-7208</orcidid></search><sort><creationdate>20190801</creationdate><title>Phenotyping an adult zebrafish lamp2 cardiomyopathy model identifies mTOR inhibition as a candidate therapy</title><author>Dvornikov, Alexey V. ; Wang, Mingmin ; Yang, Jingchun ; Zhu, Ping ; Le, Tai ; Lin, Xueying ; Cao, Hung ; Xu, Xiaolei</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c459t-a06eb26857f1a4755bee36989642516e2555a27e096919a695a6d7e096436a13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Animals</topic><topic>Cardiac contractility</topic><topic>Cardiomegaly - genetics</topic><topic>Cardiomyopathy</topic><topic>Danon disease</topic><topic>Disease modeling</topic><topic>Disease Models, Animal</topic><topic>Gene Knockout Techniques</topic><topic>Glycogen Storage Disease Type IIb - genetics</topic><topic>Glycogen Storage Disease Type IIb - metabolism</topic><topic>Hypertrophic remodeling</topic><topic>Lysosomal-Associated Membrane Protein 2 - genetics</topic><topic>Lysosomal-Associated Membrane Protein 2 - metabolism</topic><topic>mTOR</topic><topic>Myocardial Contraction - genetics</topic><topic>Myocardium - metabolism</topic><topic>Myofibrils - metabolism</topic><topic>Phenotype</topic><topic>Receptors, Adrenergic, beta - metabolism</topic><topic>Single myofibril</topic><topic>Stroke Volume</topic><topic>TOR Serine-Threonine Kinases - antagonists & inhibitors</topic><topic>TOR Serine-Threonine Kinases - genetics</topic><topic>TOR Serine-Threonine Kinases - metabolism</topic><topic>Ventricular Remodeling - genetics</topic><topic>Zebrafish</topic><topic>Zebrafish - genetics</topic><topic>Zebrafish - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Dvornikov, Alexey V.</creatorcontrib><creatorcontrib>Wang, Mingmin</creatorcontrib><creatorcontrib>Yang, Jingchun</creatorcontrib><creatorcontrib>Zhu, Ping</creatorcontrib><creatorcontrib>Le, Tai</creatorcontrib><creatorcontrib>Lin, Xueying</creatorcontrib><creatorcontrib>Cao, Hung</creatorcontrib><creatorcontrib>Xu, Xiaolei</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of molecular and cellular cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dvornikov, Alexey V.</au><au>Wang, Mingmin</au><au>Yang, Jingchun</au><au>Zhu, Ping</au><au>Le, Tai</au><au>Lin, Xueying</au><au>Cao, Hung</au><au>Xu, Xiaolei</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Phenotyping an adult zebrafish lamp2 cardiomyopathy model identifies mTOR inhibition as a candidate therapy</atitle><jtitle>Journal of molecular and cellular cardiology</jtitle><addtitle>J Mol Cell Cardiol</addtitle><date>2019-08-01</date><risdate>2019</risdate><volume>133</volume><spage>199</spage><epage>208</epage><pages>199-208</pages><issn>0022-2828</issn><eissn>1095-8584</eissn><abstract>Adult zebrafish is an emerging vertebrate model for studying genetic basis of cardiomyopathies; but whether the simple fish heart can model essential features of hypertrophic cardiomyopathy (HCM) remained unknown. Here, we report a comprehensive phenotyping of a lamp2 knockout (KO) mutant. LAMP2 encodes a lysosomal protein and is a causative gene of Danon disease that is characterized by HCM and massive autophagic vacuoles accumulation in the tissues. There is no effective therapy yet to treat this most lethal cardiomyopathy in the young. First, we did find the autophagic vacuoles accumulation in cardiac tissues from lamp2 KO. Next, through employing a set of emerging phenotyping tools, we revealed heart failure phenotypes in the lamp2 KO mutants, including decreased ventricular ejection fraction, reduced physical exercise capacity, blunted β-adrenergic contractile response, and enlarged atrium. We also noted changes of the following indices suggesting cardiac hypertrophic remodeling in lamp2 KO: a rounded heart shape, increased end-systolic ventricular volume and density of ventricular myocardium, elevated actomyosin activation kinetics together with increased maximal isometric tension at the level of cardiac myofibrils. Lastly, we assessed the function of lysosomal-localized mTOR on the lamp2-associated Danon disease. We found that haploinsufficiency of mtor was able to normalize some characteristics of the lamp2 KO, including ejection fraction, β-adrenergic response, and the actomyosin activation kinetics. In summary, we demonstrate the feasibility of modeling the inherited HCM in the adult zebrafish, which can be used to develop potential therapies.
[Display omitted]
•Zebrafish has a single LAMP2 homologue.•Loss-of-function of lamp2 in zebrafish models human Danon disease•Both metabolic abnormality and cardiac dysfunction are recapitulated.•mtor inhibition attenuates cardiac dysfunction while metabolic abnormality persists.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>31228518</pmid><doi>10.1016/j.yjmcc.2019.06.013</doi><tpages>10</tpages><orcidid>https://orcid.org/0000-0003-4197-7208</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0022-2828 |
ispartof | Journal of molecular and cellular cardiology, 2019-08, Vol.133, p.199-208 |
issn | 0022-2828 1095-8584 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6705397 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Animals Cardiac contractility Cardiomegaly - genetics Cardiomyopathy Danon disease Disease modeling Disease Models, Animal Gene Knockout Techniques Glycogen Storage Disease Type IIb - genetics Glycogen Storage Disease Type IIb - metabolism Hypertrophic remodeling Lysosomal-Associated Membrane Protein 2 - genetics Lysosomal-Associated Membrane Protein 2 - metabolism mTOR Myocardial Contraction - genetics Myocardium - metabolism Myofibrils - metabolism Phenotype Receptors, Adrenergic, beta - metabolism Single myofibril Stroke Volume TOR Serine-Threonine Kinases - antagonists & inhibitors TOR Serine-Threonine Kinases - genetics TOR Serine-Threonine Kinases - metabolism Ventricular Remodeling - genetics Zebrafish Zebrafish - genetics Zebrafish - metabolism |
title | Phenotyping an adult zebrafish lamp2 cardiomyopathy model identifies mTOR inhibition as a candidate therapy |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-21T21%3A05%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Phenotyping%20an%20adult%20zebrafish%20lamp2%20cardiomyopathy%20model%20identifies%20mTOR%20inhibition%20as%20a%20candidate%20therapy&rft.jtitle=Journal%20of%20molecular%20and%20cellular%20cardiology&rft.au=Dvornikov,%20Alexey%20V.&rft.date=2019-08-01&rft.volume=133&rft.spage=199&rft.epage=208&rft.pages=199-208&rft.issn=0022-2828&rft.eissn=1095-8584&rft_id=info:doi/10.1016/j.yjmcc.2019.06.013&rft_dat=%3Cproquest_pubme%3E2245641678%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2245641678&rft_id=info:pmid/31228518&rft_els_id=S0022282819301348&rfr_iscdi=true |